Clinical Research Directory
Browse clinical research sites, groups, and studies.
Omega-3 Supplementation for Pediatric Migraine
Sponsor: University of North Carolina, Chapel Hill
Summary
The purpose of the study is to assess the biochemical and clinical effects of omega-3 polyunsaturated fatty acid (PUFA) supplementation in youth suffering from migraine, including its effects on migraine disability, psychological distress, and overall quality of life. This study duration 12 weeks.
Official title: Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids in Pediatric Migraine Patients
Key Details
Gender
All
Age Range
10 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
58
Start Date
2025-04-17
Completion Date
2026-03
Last Updated
2026-02-25
Healthy Volunteers
No
Conditions
Interventions
Omega 3 Polyunsaturated Fats
Omega-3 PUFA dietary supplement daily for 12 weeks. The intervention is 1 teaspoon of liquid omega-3 containing oil profile 40% EPA / 60% DHA.
Matching Placebo
The placebo is a matched 1 teaspoon liquid of coconut oil, consisting mainly of saturated fatty acids and lacking omega-3 fatty acids.
Locations (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States